nardosinone has been researched along with Idiopathic Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, LH; Guo, JY; Li, JY; Li, QY; Shi, JL; Wan, GH; Wang, XM; Wang, YQ; Wang, ZY; Wei, XJ; Yang, X; Yao, ZW | 1 |
1 other study(ies) available for nardosinone and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Nardosinone regulates the slc38a2 gene to alleviate Parkinson's symptoms in rats through the GABAergic synaptic and cAMP pathways.
Topics: Animals; Parkinson Disease; Parkinson Disease, Secondary; Polycyclic Sesquiterpenes; Rats; Rotenone | 2022 |